8 May 2017
The Symposium on Translational Epigenetics will take place at the Institute of Molecular Biology (IMB) located on the campus of the Johannes Gutenberg University of Mainz (JGU), Germany, on Monday 8 May 2017. Epigenetics is a rapidly expanding field, which plays a key role in a wide range of biological processes. These include, for example, embryonic development, ageing and the adaptation of organisms to their environments. Moreover, epigenetics impacts a broad spectrum of disease processes. Epigenetic mechanisms have, for instance, been shown to contribute significantly to a number of major pathologies, including metabolic disorders, rheumatoid arthritis, allergies, cardiovascular disease, mental illness, neurodegenerative diseases and cancer. Understanding the molecular mechanisms underlying the epigenetic control of gene expression is therefore crucial to addressing some of the most fundamental open questions in biology and medicine.
Epigenetics is a rapidly growing area of investigation in biomedicine and may be key to developing novel therapies for some of the most important and intractable diseases. This symposium aims to explore some of these areas of investigation, promote discussion and potentially forge partnerships for future research.
Please note: The poster has not been updated yet and contains the old affiliations of Dr Armstrong and Dr Wahlestedt. Their current affiliations can be found in the list of speakers as well as in the tentative programme.
- Scott Armstrong - Dana-Farber Cancer Institute, Harvard Medical School, USA
- Philip Avner - EMBL, Monterotondo, Italy
- Stephen Baylin - Johns Hopkins University, Baltimore, USA
- Philip A. Marsden - University of Toronto, Canada
- Guo-Li Ming - University of Pennsylvania, Philadelphia, USA
- Moshe Szyf - McGill University, Montreal, Canada
- Claes Wahlestedt - University of Miami Miller School of Medicine, Florida, USA
- Jörn Walter - Saarland University, Saarbrücken, Germany
The presentations by the invited speakers will be complemented by short-talks.
- Andreas Diefenbach – University Medical Center (UMC), Mainz, Germany
- Peter Galle – University Medical Center (UMC), Mainz, Germany
- Vijay Tiwari – Institute of Molecular Biology (IMB), Mainz, Germany
A preliminary programme can be found here.
Registration is now open, please register here.
The deadline for registrations is Sunday 23 April 2017.